G-Therapeutics secures EUR26 million in Series A financing
G-Therapeutics has secured up to EUR26 million in a Series A financing round from an investment syndicate consisting of Gimv, Wellington Partners, LSP and Inkef Capital alongside the company’s founders/management. This investment will fund the company’s clinical trials up to CE mark (EU) and IDE (US) approval. G-Therapeutics (http://gtherapeutics.com/#About) develops
